Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Tube-Shunt Surgery for Glaucoma

Surgery Overview

Tube-shunt surgery (seton glaucoma surgery) involves placing a flexible plastic tube with an attached silicone drainage pouch in the eye to help drain fluid (aqueous humor) from the eye. This type of surgery is usually done after a trabeculectomy that failed. If a person already has or is likely to form scar tissue in the eye, this type of surgery may be done at the start.

Tube-shunt surgery can be done with the person asleep (general anesthesia) or with anesthetic applied only to the eye (local anesthesia).

What To Expect

Most people don't have to be admitted to the hospital. But children who have the surgery may stay in the hospital overnight. And in some cases, your doctor may recommend that you stay in the hospital overnight after surgery.

You will probably see the doctor within a day after tube-shunt surgery and several other times during the weeks after surgery, depending on your recovery. It is very important to keep these appointments.

After surgery, antibiotics may be applied to the eye. They may also be injected under the lining of the eyelid (conjunctiva) at the time of the surgery. At the end of surgery, the eyelid is usually taped shut, and a hard covering (eye shield) is placed over the eye. Corticosteroid medicines are usually applied to the eye for about 1 to 2 months after surgery to reduce inflammation in the eye.

Physical activity that might jar the eye needs to be avoided after surgery. For several weeks after surgery, you will probably need to avoid bending, lifting, and straining.

After surgery, people who have problems with constipation may need to take laxatives to avoid straining while trying to pass stools. Straining can raise the pressure inside the eye. Your doctor may suggest wearing a shield at night to avoid rubbing the eye when you sleep.

Why It Is Done

Tube-shunt surgery is most often used for people who have had previous trabeculectomy surgery that was not successful, usually due to scarring.

Tube-shunt surgery is also frequently used to treat glaucoma when a person has a:

  • Difficult case of glaucoma and the doctor thinks that other surgical methods may fail.
  • Form of glaucoma in which new blood vessels grow on the colored part of the eye, or iris. This is called neovascular glaucoma and occurs primarily in people who have diabetes or who have vascular diseases in the eye. It is difficult to control.
  • Corneal transplant, which is a surgery to replace the clear surface on the front of the eye (cornea).

How Well It Works

More than half of tube-shunt surgeries are successful. This surgery has been shown to reduce intraocular pressure (IOP) and the need for further glaucoma treatment.footnote 1

Risks

Complications of tube-shunt surgery that may occur right after surgery include:

  • High pressure in the eye, causing the space in the front part of the eye (anterior chamber) to collapse (malignant glaucoma).
  • Inflammation in the eye.
  • Bleeding or blood in the eye (hyphema).
  • Softening of the eyeball due to fluid loss (hypotony).
  • Movement of the tube causing it to come in contact with the clear cover of the eye (cornea), the iris, or the lens. This can affect vision or proper function of the eye.

Late complications of tube-shunt surgery include:

  • Scar tissue forming around the device. The chances of this complication can be reduced if medicines, such as steroids, are used.
  • Softening of the eyeball due to fluid loss (hypotony), leading to clouding of the lens (cataract).
  • Infection in the eye.
  • Blood in the eye (hyphema).
  • Eye muscle imbalance, resulting in double vision.

References

Citations

  1. Gedde SJ, et al. (2020). Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology, 127(3): 333–345. DOI: 10.1016/j.ophtha.2019.10.002. Accessed May 3, 2022.

Credits

Current as of: July 31, 2024

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: July 31, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Houston Cardiovascular Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded HCA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary